VASP and hyperuricemia: After adjustment for differences in patient characteristics by multivariate regression analyses, hyperuricemia was significantly associated with platelet surface expression of activated GPIIb/IIIa, levels of sCD40L, and on-treatment residual ADP-inducible platelet reactivity by LTA, MEA, and the VASP assay (Table 3).